Main navigation
Search Results
-
-
Press release - 23/01/2025 How the Ebola virus replicates in cells
Like all viruses, the Ebola virus is dependent on host cells in order to replicate. Researchers at Heidelberg University Hospital, in collaboration with colleagues from the Friedrich Loeffler Institute, have been able to show for the first time using state-of-the-art imaging techniques how the replication compartments of the Ebola virus change during replication in infected cells.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-ebola-virus-replicates-cells -
Press release - 23/01/2025 ERC Funding for „EmbryoNet-AI“
Konstanz biologist Patrick Müller receives a Proof of Concept Grant from the European Research Council for his project "EmbryoNet-AI". Its goal is the further development of an AI-supported platform for the automated evaluation of experiments – for example, in drug development.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/erc-funding-embryonet-ai -
-
Press release - 20/01/2025 New approach to fighting cancer: energy trap for tumor cells
Glycolysis is an important sugar degradation pathway that cancer cells in particular depend on. Scientists at the German Cancer Research Center (DKFZ) have now shown that liver cancer cells in mice and humans depend on a key enzyme of glycolysis, Aldolase A. When it is switched off, glycolysis reverses from an energy-producing to an energy-consuming process.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-approach-fighting-cancer-energy-trap-tumor-cells -
Event - - DMEA 2025 - Connecting Digital Health
Berlin, Germany , Messehttps://www.gesundheitsindustrie-bw.de/en/event/dmea-2025-connecting-digital-health -
Event - - Bio Europe Spring 2025
Milano, Italy, Messehttps://www.gesundheitsindustrie-bw.de/en/event/bio-europe-spring-2025 -
Press release - 20/01/2025 PAMSARC: New study at the NCT Heidelberg links research and clinical action
Young patients suffering from two aggressive sarcoma types can now participate in the innovative PAMSARC therapy study at the NCT Heidelberg. The study uses molecular biological methods and tests the extent to which a new drug can improve the poor prognosis for these tumours.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/pamsarc-new-study-nct-heidelberg-links-research-and-clinical-action -
Press release - 17/01/2025 The Minister President of Baden Wuerttemberg, Winfried Kretschmann, honors cutting-edge research at the Max Planck Institutes in Tübingen
Winfried Kretschmann, the Minister President of Baden-Württemberg, Germany, visited the Max Planck Institutes for Biology Tübingen and Biological Cybernetics. During his tour, he commended the outstanding basic research in the natural sciences. He was particularly impressed by the innovative research projects spanning developmental and evolutionary biology, as well as neuroscience.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/minister-president-baden-wuerttemberg-winfried-kretschmann-honors-cutting-edge-research-max-planck-institutes-tubingen -
Press release - 16/01/2025 New weapons against viruses
Dr. Petr Chlanda, virologist and research group leader at the Heidelberg Medical Faculty of Heidelberg University, has been awarded more than 720,000 euros in funding from the European Union for his research into new therapies against viruses. His work is part of the interdisciplinary, international DEFENDER project, which is developing innovative approaches to combat emerging and re-emerging viruses.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-weapons-against-viruses -
Event - - MedtecSUMMIT 2025 - For Innovators. For Leaders. For YOU
Nürnberg, Germany , Registration deadline: Kongress/Symposiumhttps://www.gesundheitsindustrie-bw.de/en/event/medtecsummit-2025-innovators-leaders-you -
Event - Innovation for Health 2025
Rotterdam, Netherlands, Kongress/Symposiumhttps://www.gesundheitsindustrie-bw.de/en/event/innovation-health-2025 -
-
Event - - Arab Health 2025
Dubai, Messehttps://www.gesundheitsindustrie-bw.de/en/event/arab-health-2025 -
Press release - 15/01/2025 Similarities discovered between vascular calcification and bone growth
University of Tübingen research team observes biochemical process in living cells – indications of new approach to preventing heart attacks and strokes
https://www.gesundheitsindustrie-bw.de/en/article/press-release/similarities-discovered-between-vascular-calcification-and-bone-growth -
Press release - 14/01/2025 Epigenetics ensures placenta functioning
If the development of blood vessels in the placenta is impaired, fetal growth retardation may result. Scientists from the German Cancer Research Center (DKFZ) and the Mannheim Medical Faculty of Heidelberg University discovered that the correct development of functioning blood vessels in the mouse placenta is controlled epigenetically: One of the enzymes that modify gene activity using methyl groups is responsible.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/epigenetics-ensures-placenta-functioning -
Press release - 13/01/2025 New tool for synthetic biology
Scientists at the University of Stuttgart have succeeded in controlling the structure and function of biological membranes with the help of "DNA origami". The system they developed may facilitate the transportation of large therapeutic loads into cells. This opens up a new way for the targeted administration of medication and other therapeutic interventions.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-tool-synthetic-biology -
Save the date - - Diagnostics-4-Future Conference 2025
Konstanz, Germany , Kongress/Symposiumhttps://www.gesundheitsindustrie-bw.de/en/event/diagnostics-4-future-conference-2025 -
-
Press release - 10/01/2025 MedTech Company KARL STORZ Acquires British AI Specialist Innersight Labs
The MedTech company KARL STORZ announces the acquisition of the innovative software manufacturer Innersight Labs Ltd. (ISL) headquartered in London. In addition to state-of-the-art endoscopes, high-end medical devices, and integrated solutions for the operating room, KARL STORZ is also continuing to expand in innovative software solutions. Its large customer base, including top-class physicians worldwide, can now look forward to 3D models.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/medtech-company-karl-storz-acquires-british-ai-specialist-innersight-labs-1 -
New polymer for wound care - 09/01/2025 Thermoresponsive adhesive for pain-free removal of wound dressings
Plasters or wound dressings can only perform their intended function if they adhere securely to the skin. However, they are often painful to remove, and in some cases, damage delicate newly formed tissue. Researchers at the University of Freiburg have developed an innovative polymer that adheres reliably at body temperature but can be easily and painlessly removed, leaving no residue, after being cooled.
https://www.gesundheitsindustrie-bw.de/en/article/news/thermoresponsive-adhesive-pain-free-removal-wound-dressings -
Press release - 07/01/2025 Revolutionising cancer therapy with protein design
A new family of protein-based antagonists has been created by researchers that efficiently block the granulocyte-colony stimulating factor receptor (G-CSFR), which is essential for the development of leukaemia and other inflammatory illnesses. This groundbreaking work paves the way for targeted therapies that could revolutionise treatment options for patients suffering from these conditions.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/revolutionising-cancer-therapy-protein-design -
Press release - 07/01/2025 Researchers have a better understanding of how our cells dispose of waste while developing ways to control it
A research team from Freiburg and Frankfurt has discovered how cells recognise and internally break down waste. The results are relevant for the development of therapies for diseases such as Alzheimer’s.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/researchers-have-better-understanding-how-our-cells-dispose-waste-while-developing-ways-control-it -
Press release - 03/01/2025 New approaches against metastatic breast cancer: mini-tumors from circulating cancer cells
Tumor cells circulating in the blood are the "germ cells" of breast cancer metastases. They are rare and could not be propagated in the culture dish until now, which made research into therapy resistance difficult. A team from the DKFZ, the Heidelberg Stem Cell Institute HI-STEM and the NCT Heidelberg has now succeeded for the first time in cultivating stable tumor organoids directly from blood samples of breast cancer patients.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-approaches-against-metastatic-breast-cancer-mini-tumors-circulating-cancer-cells -
Press release - 19/12/2024 Antibody that neutralizes inhibitory factors involved in nerve regeneration leads to enhanced motor function after acute spinal cord injury
Antibodies can improve the rehabilitation of people with acute spinal cord injury. Researchers at 13 clinics in Germany, Switzerland, the Czech Republic and Spain have investigated this with promising results. For the first time, it was possible to identify patient groups that displayed a clinically relevant treatment effect. A follow-up study will start in December 2024.
https://www.gesundheitsindustrie-bw.de/en/article/press-release/antibody-neutralizes-inhibitory-factors-involved-nerve-regeneration-leads-enhanced-motor-function-after-acute-spinal-cord-injury